Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Down 49.2% in May

Posted by James Conley on Jun 13th, 2026

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a large drop in short interest in the month of May. As of May 29th, there was short interest totaling 19,405 shares, a drop of 49.2% from the May 14th total of 38,212 shares. Approximately 0.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 24,657 shares, the short-interest ratio is currently 0.8 days.

Invesco Nasdaq Biotechnology ETF Trading Up 0.2%

Invesco Nasdaq Biotechnology ETF stock opened at $29.57 on Friday. The stock has a market cap of $66.83 million, a price-to-earnings ratio of 17.03 and a beta of 0.62. The company’s 50-day moving average price is $29.42 and its two-hundred day moving average price is $29.11. Invesco Nasdaq Biotechnology ETF has a 52 week low of $20.67 and a 52 week high of $30.50.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 27th. Shareholders of record on Monday, March 23rd were paid a dividend of $0.0361 per share. The ex-dividend date of this dividend was Monday, March 23rd. This represents a $0.14 annualized dividend and a yield of 0.5%.

Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF

Several large investors have recently bought and sold shares of IBBQ. WMS Group LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at about $4,255,000. LPL Financial LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at about $1,220,000. Independent Advisor Alliance bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at about $653,000. GeoWealth Management LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the 3rd quarter valued at about $451,000. Finally, Orion Porfolio Solutions LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at about $392,000.

About Invesco Nasdaq Biotechnology ETF

(Get Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.